# Dyania Health

> Dyania Health builds Synapsis AI, a medically trained large language model that reads unstructured electronic medical records - physician notes, pathology reports, imaging notes - and answers complex clinical questions with roughly 95% accuracy in under a second per record. Deployed inside health systems' own firewalls, the platform automates clinical trial pre-screening, chart abstraction, observational studies, and registry reporting, turning weeks of manual nurse and physician chart review into minutes. Founded in 2020 by former Morgan Stanley dealmaker Eirini Schlosser and headquartered in Jersey City with a team in Athens, the company raised a $10M Series A in 2024 and counts Cleveland Clinic among its earliest enterprise partners.

- **Founded:** 2020
- **Headquarters:** Jersey City, New Jersey, United States
- **Founders:** Eirini Schlosser (Founder & CEO)
- **Team size:** ~45 employees
- **Products:** Synapsis AI, Patient Finder, Automated chart abstraction & registry reporting
- **Notable:** Melanoma trial: identified eligible patients in 2.5 minutes at 96% accuracy vs. 427 minutes (95%) for a specialized nurse and 540 minutes (88%) for an oncology nurse., DepleTTR-CM cardiology trial: analyzed 1.2 million patient records, reviewed 1,476 in one week, and identified 30 eligible participants vs. 14 over 90 days with standard recruitment., Models consistently outperform human experts in medical chart review.

## Products & services

- **Synapsis AI** — A proprietary, medically trained large language model that reads unstructured EMRs - physician notes, pathology reports, imaging notes - alongside structured data, and deduces answers to complex clinical questions with roughly 95% accuracy in under 0.5 seconds per record. Runs locally inside a health system's firewall to maintain HIPAA and GDPR compliance.
- **Patient Finder** — Clinical trial pre-screening and recruitment tool that converts records into searchable structured data and precision-matches patients against trial eligibility criteria across an entire health system.
- **Automated chart abstraction & registry reporting** — Automates manual chart review for observational studies, study feasibility assessment, real-world data studies, and complex registry reporting, dramatically reducing manual nurse and physician workload.

## Achievements

- Melanoma trial: identified eligible patients in 2.5 minutes at 96% accuracy vs. 427 minutes (95%) for a specialized nurse and 540 minutes (88%) for an oncology nurse.
- DepleTTR-CM cardiology trial: analyzed 1.2 million patient records, reviewed 1,476 in one week, and identified 30 eligible participants vs. 14 over 90 days with standard recruitment.
- Models consistently outperform human experts in medical chart review.
- CEO Eirini Schlosser named to Fortune Greece 40 Under 40 and Inc.'s Female Founders 500.
- Recognized in the Digital Health 100 and Fierce Healthcare Innovation Awards.

## Latest updates

- **2025-08** — Cleveland Clinic announced an enterprise-wide rollout of Synapsis AI across its clinical research system following pilots in cardiology, oncology, and neurology.
- **2025-01** — Selected for the CancerX accelerator program.
- **2024-10** — Closed a $10M Series A led by HealthX Ventures with Tech Square Ventures and Cleveland Clinic Ventures.

## Links

- Website: https://dyaniahealth.com
- LinkedIn: https://www.linkedin.com/company/dyaniahealth

---

Profile page: https://yespress.io/dyania-health
Published by YesPress — https://yespress.io
Last updated: 2026-06-09